$NASDAQ:ATRC

Atricure Intrinsic Stock Value – ATRICURE sees decrease in major investment as Dimensional Fund Advisors LP cuts stake by 28%

🌧️Trending News ATRICURE ($NASDAQ:ATRC), a leading medical device company focused on developing and commercializing innovative solutions for the treatment of [...]

ATRICURE Offers Lifeline for Cash-Strapped Investors in Need of Financial Support

☀️Trending News ATRICURE ($NASDAQ:ATRC) is a leading medical device company that specializes in developing innovative treatments for cardiac arrhythmias. Despite [...]

By |September 12, 2024|Categories: Medical Instruments & Supplies|Tags: , , |0 Comments

Atricure Stock Fair Value – AtriCure Rating Upgraded to ‘Buy’ – Here’s What You Need to Know

🌥️Trending News ATRICURE ($NASDAQ:ATRC): AtriCure Inc. (NASDAQ: ATRC) has recently had its stock upgraded by Wall Street analysts to a [...]

ATRICURE Sees 19.4% YOY Revenue Growth, Totaling $100.9 Million in Q2 2023

☀️Earnings Overview Atricure ($NASDAQ:ATRC) reported total revenue of USD 100.9 million for the second quarter of FY2023, ending June 30 [...]

Atricure Anticipates a Resilient Quarter: An In-depth Analysis of the Upcoming Earnings Call

🌥️Introduction: Atricure, a leading innovator in surgical ablation systems, is set to announce its second-quarter earnings results on July 25, [...]

Atricure Intrinsic Value Calculator – PNC Financial Services Group Reduces Stake in AtriCure, by Selling 948 Shares

☀️Trending News ATRICURE ($NASDAQ:ATRC): AtriCure, Inc. (ATRC) is a medical technology company that specializes in innovative treatments for atrial fibrillation [...]

Go to Top